Sign in

CIK 0001396814

  • Large accelerated filer

Pacira BioSciences, Inc.

Sign in to watch
Ticker
PCRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
510619477
Phone
+1 650-242-8052
Business address
2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
Former names
Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$217,920
in 1 filing, $218K under 10b5-1 plans

Net −$217,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. RIKER LAUREN −$218K Senior Vice President, Finance sold 9% of stake
Date Insider Transaction Shares Price Value Owned after
2023-06-14 Froimson Mark Director Grant or award · Stock Option (Right to Buy) +12,925 12,925
2022-06-08 Froimson Mark Director Grant or award +1,160 6,068
2022-06-08 Froimson Mark Director Grant or award · Stock Option (Right to Buy) +8,225 8,225
2022-05-09 Froimson Mark Director Sale −1,000 $59.37 $59K 4,908
2021-12-17 Froimson Mark Director Gift −400 5,908
2021-06-09 Froimson Mark Director Grant or award +1,066 6,308
2021-06-09 Froimson Mark Director Grant or award · Stock Option (Right to Buy) +7,626 7,626
2021-03-15 Froimson Mark Director Sale −734 $72.26 $53K 5,242
2020-06-09 Froimson Mark Director Grant or award +1,260 5,976
2020-06-09 Froimson Mark Director Grant or award · Stock Option (Right to Buy) +8,027 8,027
2019-12-16 Froimson Mark Director Gift −300 4,716

Page 2 of 2 · 31 trades